Publications
publications by categories in reversed chronological order.
2022
-
Optimized high-throughput screening of non-coding variants identified from genome-wide association studiesNucleic Acids Research, Dec 2022
-
Dynamic phase separation of the androgen receptor and its coactivators key to regulate gene expressionNucleic Acids Research, Dec 2022
-
Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potentialNature Communications, Nov 2022
-
Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulationNature Genetics, Sep 2022
-
EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilitiesCell Death & Disease, Aug 2022
-
Epigenetic-focused CRISPR/Cas9 screen identifies ASH2L as a regulator of glioblastoma cell survivalbioRxiv, Aug 2022
-
Protein Scaffold-Based Multimerization of Soluble ACE2 Efficiently Blocks SARS-CoV-2 Infection In Vitro and In VivoAdvanced Science, Jul 2022
-
-
Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen IndependenceCancer Discovery, Jun 2022
-
Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasisNature Cell Biology, Apr 2022
-
Association of B7-H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancerCancer, Mar 2022
-
2021
-
Histologically benign PI-RADS 4 and 5 lesions contain cancer-associated epigenetic alterationsThe Prostate, Oct 2021
-
Development of 2-(5, 6, 7-Trifluoro-1H-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate CancerJournal of Medicinal Chemistry, Oct 2021
-
-
Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate CancerCancers, Jul 2021
-
2020
-
Androgen receptor-binding sites are highly mutated in prostate cancerNature Communications, Feb 2020
2019
-
DeepCOP: deep learning-based approach to predict gene regulating effects of small moleculesBioinformatics, Aug 2019
-
Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancerOncogene, Dec 2019
-
Androgen receptor plasticity and its implications for prostate cancer therapyCancer Treatment Reviews, Dec 2019
-
ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate CancerCancer Cell, Mar 2019
2018
-
Small molecule-induced degradation of the full length and V7 truncated variant forms of human androgen receptorEuropean Journal of Medicinal Chemistry, Sep 2018
-
-
Impact of the ST101 clone on fatality among patients with colistin-resistant Klebsiella pneumoniae infectionJournal of Antimicrobial Chemotherapy, Feb 2018
2017
-
KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAILCell Death & Disease, Jun 2017
-
Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approachBritish Journal of Pharmacology, May 2017
-
Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathwayWellcome Open Research, Jun 2017
2016
-
Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma MultiformeCancer Biology & Therapy, Mar 2016
-
Cytotoxicity and mitogenicity assays with real-time and label-free monitoring of human granulosa cells with an impedance-based signal processing technology intergrating micro-electronics and cell biologyReproductive Toxicology, Apr 2016
2015
-
Determining the origin of synchronous multifocal bladder cancer by exome sequencingBMC Cancer, Nov 2015
-
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cellsNature Communications, Jan 2015
2014
-
Characterisation of a putative AraC transcriptional regulator from Mycobacterium smegmatisTuberculosis, Dec 2014
-
Deletion of conserved protein phosphatases reverses defects associated with mitochondrial DNA damage in Saccharomyces cerevisiaeProceedings of the National Academy of Sciences, Jan 2014
2013
-
Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate CancerMolecular Cancer Therapeutics, Nov 2013
-
New Therapeutics to Treat Castrate-Resistant Prostate CancerThe Scientific World Journal, Nov 2013
-
Genetic variants of MARCO are associated with susceptibility to pulmonary tuberculosis in a Gambian populationBMC Medical Genetics, Apr 2013
-
Targeting the Binding Function 3 (BF3) Site of the Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzimidazole DerivativesJournal of Medicinal Chemistry, Jan 2013